Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Garofoli

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
HIV Medicine|September 30, 2025
Impact on weight of a Doravirine switch in people living with HIVNina Garofoli, Philippe Flandre, Jean-Paul Vincensini, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2024
Incidence and factors associated with PrEP discontinuation in FranceNina Garofoli, Martin Siguier, Olivier Robineau, et al.
Jac-Antimicrobial Resistance|March 7, 2024
Enterococcal endocarditis management and relapsesNina Garofoli, Véronique Joly, Diane Le Pluart, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
HIV Medicine|September 30, 2025
Impact on weight of a Doravirine switch in people living with HIVNina Garofoli, Philippe Flandre, Jean-Paul Vincensini, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2024
Incidence and factors associated with PrEP discontinuation in FranceNina Garofoli, Martin Siguier, Olivier Robineau, et al.
Jac-Antimicrobial Resistance|March 7, 2024
Enterococcal endocarditis management and relapsesNina Garofoli, Véronique Joly, Diane Le Pluart, et al.
Pageof 1